Tech Company Financing Transactions
Diaceutics Funding Round
On 4/6/2018, Diaceutics landed $5 million in funding from Silicon Valley Bank and WhiteRock Capital Partners.
Transaction Overview
Company Name
Announced On
4/6/2018
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Silicon Valley Bank (Clive Lennox)
WhiteRock Capital Partners (Andrew Gowdy)
Proceeds Purpose
Diaceutics will use the funding to invest in the data analytics services it provides to pharmaceutical clients and continue to expand its laboratory network.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
2001 US-46 Waterview Plz. 310
Parsippany-Troy Hills, NY 07054
USA
Parsippany-Troy Hills, NY 07054
USA
Phone
Website
Email Address
Overview
Diaceutics is a global group of experts from the laboratory, diagnostic and pharmaceutical industries. Our goal is to help pharmaceutical companies integrate diagnostic testing into their treatment pathways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Keeling
Chief Financial Officer
Philip White
Chief Operating Officer
Ryan Keeling
VP - Bus. Development
David Sweet
VP - Finance
Kevin Monaghan
VP - Human Resources
Sarah Bondi
VP - Marketing
Steve Vitale
Browse more venture capital transactions:
Prev: 4/6/2018: Sotera Medical venture capital transaction
Next: 4/6/2018: Suplari venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs